Drug
C-KAD Ophthalmic Solution
C-KAD Ophthalmic Solution is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
3
75%
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
3(75.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(1)
Other(3)
Detailed Status
unknown3
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 23 (75.0%)
N/A1 (25.0%)
Trials by Status
unknown375%
completed125%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension
NCT00825396
unknownphase_2
An Open-Label Study of the Effect of an Ophthalmic Solution on Asteroid Hyalosis
NCT00825942
unknownphase_2
Dose-Ranging Study of an Ophthalamic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear Cataract
NCT00825721
unknownphase_2
Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract
NCT00793091
Clinical Trials (4)
Showing 4 of 4 trials
NCT00825396Not Applicable
An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension
NCT00825942Phase 2
An Open-Label Study of the Effect of an Ophthalmic Solution on Asteroid Hyalosis
NCT00825721Phase 2
Dose-Ranging Study of an Ophthalamic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear Cataract
NCT00793091Phase 2
Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4